SEC Filings

Filing date	Form	Description	View
11/06/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-066197.pdf 0001104659-18-066197.rtf 0001104659-18-066197.xls
11/06/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-066330.pdf 0001104659-18-066330.rtf 0001104659-18-066330.xls
10/24/18	UPLOAD	UPLOAD	View HTML 0000000000-18-033267.pdf 0000000000-18-033267.rtf
10/04/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-060457.pdf 0001104659-18-060457.rtf 0001104659-18-060457.xls
09/14/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-011431.pdf 0001179110-18-011431.rtf 0001179110-18-011431.xls
08/29/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-011003.pdf 0001179110-18-011003.rtf 0001179110-18-011003.xls
08/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-010817.pdf 0001179110-18-010817.rtf 0001179110-18-010817.xls
08/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-010820.pdf 0001179110-18-010820.rtf 0001179110-18-010820.xls
08/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-010819.pdf 0001179110-18-010819.rtf 0001179110-18-010819.xls
08/22/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-010818.pdf 0001179110-18-010818.rtf 0001179110-18-010818.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools